Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

5'-Nucleotidase

The NT5E gene encodes a membrane protein that synthesizes the conversion of extracellular nucleotides to membrane permeable nucleotides, which is important to signal transduction. Mutations cause autosomal recessive calcification of joints and arteries. Moreover it seems to play a role in calciphylaxis.

Genetests:

Clinic Method Carrier testing
Turnaround 5 days
Specimen type genomic DNA
Clinic Method Massive parallel sequencing
Turnaround 25 days
Specimen type genomic DNA
Research Method Genomic sequencing of the entire coding region
Turnaround 25 days
Specimen type genomic DNA
Clinic Method Target mutation analysis
Turnaround 20 days
Specimen type genomic DNA

Related Diseases:

Hereditary arterial and articular multiple calcification syndrome
NT5E
Calciphylaxis
FGF23
NT5E
VDR

References:

1.

Rothe H et al. (2017) Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients - Data from the German Calciphylaxis Registry.

external link
2.

Misumi Y et al. (1990) Primary structure of human placental 5'-nucleotidase and identification of the glycolipid anchor in the mature form.

external link
3.

Boyle JM et al. (1988) Assignment of ecto-5'-nucleotidase to human chromosome 6.

external link
4.

Adrian K et al. (2000) Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells.

external link
5.

Sun D et al. (2001) Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors.

external link
6.

Castrop H et al. (2004) Impairment of tubuloglomerular feedback regulation of GFR in ecto-5'-nucleotidase/CD73-deficient mice.

external link
7.

St Hilaire C et al. (2011) NT5E mutations and arterial calcifications.

external link
Update: Aug. 14, 2020
Copyright © 2005-2020 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues